06

In the final installment of The Pandemic Puzzle: Lessons from COVID-19, leaders in government, academia, health care and business said biomedical and digital health advances of the last few years will help combat future health crises.

Data suggest that between 10% and 30% of those who have had an acute SARS-CoV-2 infection will experience the persistent pattern of symptoms known as long COVID.

Efforts to design a hepatitis C vaccine, understand the genetic causes of rare diseases, map genetic regulatory elements in organ systems and understand coronavirus immune responses garner over $40 million.

Five Stanford researchers will participate in a $180 million nationwide campaign by the National Institutes of Health to understand the effect of human-genome variations on health and disease.

New medications help many people with inflammatory conditions and may ease severe COVID-19, but they carry risks.

The director of the Center for Innovation in Global Health explains how the medical community is at the center of the climate change debate.

Stanford researchers have developed a synthetic, tumor-targeting molecule that promotes immune activation and tumor regression in laboratory mice after it’s injected into their bloodstreams.

A potential COVID-19 vaccine, delivered via a squirt up the nose, shows promise in mice.

Kelsey was known for her teaching skills, her expertise in musculoskeletal disorders and her love of golden retrievers.

Psychiatrist Lawrence Fung expanded his autism research into developing a program that helps those on the spectrum find jobs.